Serotonin 2A receptor gene is associated with personality traits, but not to disorder, in patients with borderline personality disorder

Neuroscience Letters

Volumn 408, Issue 3, 2006, Pages 214-219

  Ni, Xingqun ^a   Bismil, Ramprasad ^a   Chan, Kirsten ^a   Sicard, Tricia ^a   Bulgin, Natalie ^a   McMain, Shelley ^a   Kennedy, James L ^a  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Association study; Borderline personality disorder; Candidate gene; Genetics; Personality trait; Serotonin 2A receptor gene

Indexed keywords

SEROTONIN 2A RECEPTOR;

ALLELE; ARTICLE; BORDERLINE STATE; CAUCASIAN; COMPUTER PROGRAM; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EXTRAVERSION; FEMALE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; MENTAL INSTABILITY; PERSONALITY; PERSONALITY DISORDER; PRIORITY JOURNAL; RECEPTOR GENE;

BORDERLINE PERSONALITY DISORDER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; PERSONALITY; POLYMORPHISM, GENETIC; RECEPTOR, SEROTONIN, 5-HT2A;

EID: 33749508987     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.09.002     Document Type: Article

References (58)

1. Anguelova M., Benkelfat C., and Turecki G. A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: II. Suicidal behavior. Mol. Psychiatry 8 (2003) 646-653
2. APA. Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. Am. J. Psychiatry 158 (2001) 1-52
3. Arango V., Ernsberger P., Marzuk P.M., Chen J.S., Tierney H., Stanley M., Reis D.J., and Mann J.J. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch. Gen. Psychiatry 47 (1990) 1038-1047
4. Arango V., and Underwood M.D. Serotonin chemistry in the brain of suicide victims. In: Mans R., Silverman M., and Canetto S. (Eds). Review of Suicidology (1997), Guilford Press, New York
5. Assal F., Alarcon M., Solomon E.C., Masterman D., Geschwind D.H., and Cummings J.L. Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease. Arch. Neurol. 61 (2004) 1249-1253
6. Bondy B., Kuznik J., Baghai T., Schule C., Zwanzger P., Minov C., de Jonge S., Rupprecht R., Meyer H., Engel R.R., Eisenmenger W., and Ackenheil M. Lack of association of serotonin-2A receptor gene polymorphism (T102C) with suicidal ideation and suicide. Am. J. Med. Genet. 96 (2000) 831-835
7. Bray N.J., Buckland P.R., Hall H., Owen M.J., and O'Donovan M.C. The serotonin-2A receptor gene locus does not contain common polymorphism affecting mRNA levels in adult brain. Mol. Psychiatry 9 (2004) 109-114
8. Coccaro E.F., Kavoussi R.J., Sheline Y.I., Berman M.E., and Csernansky J.G. Impulsive aggression in personality disorder correlates with platelet 5-HT2A receptor binding. Neuropsychopharmacology 16 (1997) 211-216
9. Costa P.T., and McCrae R.R. Personality disorders and the five-factor model of personality. J. Personal Disord. 4 (1990) 362-371
10. Costa P.T., and McCrae R.R. Revised NEO personality inventory: professional manual. Psychol. Assess. Resour. (1992)
11. Du L., Bakish D., Lapierre Y.D., Ravindran A.V., and Hrdina P.D. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Am. J. Med. Genet. 96 (2000) 56-60
12. Du L., Faludi G., Palkovits M., Demeter E., Bakish D., Lapierre Y.D., Sotonyi P., and Hrdina P.D. Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims. Biol. Psychiatry 46 (1999) 196-201
13. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet. Epidemiol. 25 (2003) 115-121
14. Escriba P.V., Ozaita A., and Garcia-Sevilla J.A. Increased mRNA expression of alpha2A-adrenoceptors, serotonin receptors and mu-opioid receptors in the brains of suicide victims. Neuropsychopharmacology 29 (2004) 1512-1521
15. Golimbet V.E., Alfimova M.V., Manandyan K.K., Mitushina N.G., Abramova L.I., Kaleda V.G., Oleichik I.V., Yurov Y., and Trubnikov V.I. 5HTR2A gene polymorphism and personality traits in patients with major psychoses. Eur. Psychiatry 17 (2002) 24-28
16. Heid C.A., Stevens J., Livak K.J., and Williams P.M. Real time quantitative PCR. Genome Res. 6 (1996) 986-994
17. Heisler L.K., Chu H.M., Brennan T.J., Danao J.A., Bajwa P., Parsons L.H., and Tecott L.H. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 15049-15054
18. Hrdina P.D., Demeter E., Vu T.B., Sotonyi P., and Palkovits M. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res. 614 (1993) 37-44
19. Hrdina P.D., and Du L. Levels of serotonin receptor 2A higher in suicide victims?. Am. J. Psychiatry 158 (2001) 147-148
20. Jedema H.P., and Moghaddam B. Glutamatergic control of dopamine release during stress in the rat prefrontal cortex. J. Neurochem. 63 (1994) 785-788
21. Jonsson E.G., Nothen M.M., Gustavsson J.P., Berggard C., Bunzel R., Forslund K., Rylander G., Mattila-Evenden M., Propping P., Asberg M., and Sedvall G. No association between serotonin 2A receptor gene variants and personality traits. Psychiatr. Genet. 11 (2001) 11-17
22. Kouzmenko A.P., Hayes W.L., Pereira A.M., Dean B., Burnet P.W., and Harrison P.J. 5-HT2A receptor polymorphism and steady state receptor expression in schizophrenia. Lancet 349 (1997) 1815
23. Kouzmenko A.P., Scaffidi A., Pereira A.M., Hayes W.L., Copolov D.L., and Dean B. No correlation between A(-1438)G polymorphism in 5-HT2A receptor gene promoter and the density of frontal cortical 5-HT2A receptors in schizophrenia. Hum. Hered. 49 (1999) 103-105
24. Lam L.C., Tang N.L., Ma S.L., Zhang W., and Chiu H.F. 5-HT2A T102C receptor polymorphism and neuropsychiatric symptoms in Alzheimer's disease. Int. J. Geriatr. Psychiatry 19 (2004) 523-526
25. Lauterbach E., Brunner J., Hawellek B., Lewitzka U., Ising M., Bondy B., Rao M.L., Frahnert C., Rujescu D., Muller-Oerlinghausen B., Schley J., Heuser I., Maier W., Hohagen F., Felber W., and Bronisch T. Platelet 5-HT2A receptor binding and tryptophan availability in depression are not associated with recent history of suicide attempts but with personality traits characteristic for suicidal behavior. J. Affect Disord. 91 (2006) 57-62
26. Lerer B., and Macciardi F. Pharmacogenetics of antidepressant and mood-stabilizing drugs: a review of candidate-gene studies and future research directions. Int. J. Neuropsychopharmacol. 5 (2002) 255-275
27. Lieb K., Zanarini M.C., Schmahl C., Linehan M.M., and Bohus M. Borderline personality disorder. Lancet 364 (2004) 453-461
28. Mann J.J., Stanley M., McBride P.A., and McEwen B.S. Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch. Gen. Psychiatry 43 (1986) 954-959
29. Marek G.J., and Aghajanian G.K. The electrophysiology of prefrontal serotonin systems: therapeutic implications for mood and psychosis. Biol. Psychiatry 44 (1998) 1118-1127
30. Marek G.J., Wright R.A., Schoepp D.D., Monn J.A., and Aghajanian G.K. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex. J. Pharmacol. Exp. Ther. 292 (2000) 76-87
31. Moresco F.M., Dieci M., Vita A., Messa C., Gobbo C., Galli L., Rizzo G., Panzacchi A., De Peri L., Invernizzi G., and Fazio F. In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study. Neuroimage 17 (2002) 1470-1478
32. Morris T., Robertson B., and Gallagher M. Rapid reverse transcription-PCR detection of hepatitis C virus RNA in serum by using the TaqMan fluorogenic detection system. J. Clin. Microbiol. 34 (1996) 2933-2936
33. Ni X., Trakalo J.M., Mundo E., Lee L., Parikh S., and Kennedy J.L. Family-based association study of the serotonin-2A receptor gene (5-HT2A) and bipolar disorder. Neuromol. Med. 2 (2002) 251-259
34. Nigg J.T., and Goldsmith H.H. Genetics of personality disorders: perspectives from personality and psychopathology research. Psychol. Bull. 115 (1994) 346-380
35. Nishiguchi N., Matsushita S., Suzuki K., Murayama M., Shirakawa O., and Higuchi S. Association between 5HT2A receptor gene promoter region polymorphism and eating disorders in Japanese patients. Biol. Psychiatry 50 (2001) 123-128
36. Norton N., and Owen M.J. HTR2A: association and expression studies in neuropsychiatric genetics. Ann. Med. 37 (2005) 121-129
37. Ono H., Shirakawa O., Nishiguchi N., Nishimura A., Nushida H., Ueno Y., and Maeda K. Serotonin 2A receptor gene polymorphism is not associated with completed suicide. J. Psychiatr. Res. 35 (2001) 173-176
38. Oquendo M.A., and Mann J.J. The biology of impulsivity and suicidality. Psychiatr. Clin. North Am. 23 (2000) 11-25
39. Ozaki N., Manji H., Lubierman V., Lu S.J., Lappalainen J., Rosenthal N.E., and Goldman D. A naturally occurring amino acid substitution of the human serotonin 5-HT2A receptor influences amplitude and timing of intracellular calcium mobilization. J. Neurochem. 68 (1997) 2186-2193
40. Ozaki N., Rosenthal N.E., Pesonen U., Lappalainen J., Feldman-Naim S., Schwartz P.J., Turner E.H., and Goldman D. Two naturally occurring amino acid substitutions of the 5-HT2A receptor: similar prevalence in patients with seasonal affective disorder and controls. Biol. Psychiatry 40 (1996) 1267-1272
41. Pandey G.N. Altered serotonin function in suicide. Evidence from platelet and neuroendocrine studies. Ann. N.Y. Acad. Sci. 836 (1997) 182-200
42. Polesskaya O.O., and Sokolov B.P. Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics. J. Neurosci. Res. 67 (2002) 812-822
43. Popa D., Lena C., Fabre V., Prenat C., Gingrich J., Escourrou P., Hamon M., and Adrien J. Contribution of 5-HT2 receptor subtypes to sleep-wakefulness and respiratory control, and functional adaptations in knock-out mice lacking 5-HT2A receptors. J. Neurosci. 25 (2005) 11231-11238
44. Preuss U.W., Koller G., Bahlmann M., Soyka M., and Bondy B. No association between suicidal behavior and 5-HT2A-T102C polymorphism in alcohol dependents. Am. J. Med. Genet. 96 (2000) 877-878
45. Preuss U.W., Koller G., Bondy B., Bahlmann M., and Soyka M. Impulsive traits and 5-HT2A receptor promoter polymorphism in alcohol dependents: possible association but no influence of personality disorders. Neuropsychobiology 43 (2001) 186-191
46. Roy A. Family history of suicide and neuroticism: a preliminary study. Psychiatry Res. 110 (2002) 87-90
47. Rybakowski F., Slopien A., Dmitrzak-Weglarz M., Czerski P., Rajewski A., and Hauser J. The 5-HT2A -1438 A/G and 5-HTTLPR polymorphisms and personality dimensions in adolescent anorexia nervosa: association study. Neuropsychobiology 53 (2006) 33-39
48. Savitz J.B., Cupido C.L., and Ramesar R.S. Trends in suicidology: personality as an endophenotype for molecular genetic investigations. PLoS Med. 3 (2006) e107
49. Siever L.J., Torgersen S., Gunderson J.G., Livesley W.J., and Kendler K.S. The borderline diagnosis III: identifying endophenotypes for genetic studies. Biol. Psychiatry 51 (2002) 964-968
50. Stanley B., Molcho A., Stanley M., Winchel R., Gameroff M.J., Parsons B., and Mann J.J. Association of aggressive behavior with altered serotonergic function in patients who are not suicidal. Am. J. Psychiatry 157 (2000) 609-614
51. Stanley M., and Mann J.J. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 1 (1983) 214-216
52. Takahata R., and Moghaddam B. Glutamatergic regulation of basal and stimulus-activated dopamine release in the prefrontal cortex. J. Neurochem. 71 (1998) 1443-1449
53. Tochigi M., Umekage T., Kato C., Marui T., Otowa T., Hibino H., Otani T., Kohda K., Kato N., and Sasaki T. Serotonin 2A receptor gene polymorphism and personality traits: no evidence for significant association. Psychiatr. Genet. 15 (2005) 67-69
54. Turecki G., Briere R., Dewar K., Antonetti T., Lesage A.D., Seguin M., Chawky N., Vanier C., Alda M., Joober R., Benkelfat C., and Rouleau G.A. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am. J. Psychiatry 156 (1999) 1456-1458
55. Underwood M.D., Mann J.J., and Arango V. Serotonergic and noradrenergic neurobiology of alcoholic suicide. Alcohol Clin. Exp. Res. 28 (2004) 57S-69S
56. van Heeringen C., Audenaert K., Van Laere K., Dumont F., Slegers G., Mertens J., and Dierckx R.A. Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide. J. Affect Disord. 74 (2003) 149-158
57. Warren Jr. J.T., Peacock M.L., Rodriguez L.C., and Fink J.K. An MspI polymorphism in the hyman serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis. Hum. Mol. Genet. 2 (1993) 338
58. Winstanley C.A., Dalley J.W., Theobald D.E., and Robbins T.W. Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neuropsychopharmacology 29 (2004) 1331-1343